The dystrophin gene and cognitive function in the general population

European Journal of Human Genetics

Volumn 23, Issue 6, 2015, Pages 837-843

  Vojinovic, Dina ^a,b   Adams, Hieab H H ^a   Van Der Lee, Sven J ^a   Ibrahim Verbaas, Carla A ^a   Brouwer, Rutger ^a   Van Den Hout, Mirjam C G N ^a   Oole, Edwin ^a   Van Rooij, Jeroen ^a   Uitterlinden, Andre ^a,c   Hofman, Albert ^a   Van Ijcken, Wilfred F J ^a   Aartsma Rus, Annemieke ^d   Van Ommen, GertJan B ^d,e   Ikram, M Arfan ^a   Van Duijn, Cornelia M ^a,c,e   Amin, Najaf ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Netherlands Consortium for Health Ageing   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Center of Medical Systems Biology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; DMD PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COGNITION; EXOME; FEMALE; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; POPULATION GENETICS; PRIORITY JOURNAL; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; COGNITION; DYSTROPHIN; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84929291759     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.183     Document Type: Article

References (62)

1. Hoffman EP, Brown Jr RH. Kunkel LM: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-928.
2. Anderson JL, Head SI, Rae C, Morley JW: Brain function in Duchenne muscular dystrophy. Brain 2002; 125: 4-13.
3. Cotton S, Voudouris NJ, Greenwood KM: Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol 2001; 43: 497-501.
4. Emery AEH: Duchenne Muscular Dystrophy. Oxford University Press: Oxford; New York, 2003.
5. Cotton SM, Voudouris NJ, Greenwood KM: Association between intellectual functioning and age in children and young adults with Duchenne muscular dystrophy: further results from a meta-analysis. Dev Med Child Neurol 2005; 47: 257-265.
6. Sollee ND, Latham EE, Kindlon DJ, Bresnan MJ: Neuropsychological impairment in Duchenne muscular dystrophy. J Clin Exp Neuropsychol 1985; 7: 486-496.
7. Cyrulnik SE, Fee RJ, De Vivo DC, Goldstein E, Hinton VJ: Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr 2007; 150: 474-478.
8. Wicksell RK, Kihlgren M, Melin L, Eeg-Olofsson O: Specific cognitive deficits are common in children with Duchenne muscular dystrophy. Dev Med Child Neurol 2004; 46: 154-159.
9. Hinton VJ, De Vivo DC, Nereo NE, Goldstein E, Stern Y: Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurology 2000; 54: 2127-2132.
10. Hinton VJ, Fee RJ, Goldstein EM, De Vivo DC: Verbal and memory skills in males with Duchenne muscular dystrophy. Dev Med Child Neurol 2007; 49: 123-128.
11. Mento G, Tarantino V, Bisiacchi PS: The neuropsychological profile of infantile Duchenne muscular dystrophy. Clin Neuropsychol 2011; 25: 1359-1377.
12. D'Angelo MG, Lorusso ML, Civati F et al: Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatr Neurol 2011; 45: 292-299.
13. Perronnet C, Vaillend C: Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. J Biomed Biotechnol 2010; 2010: 849426.
14. Hendriksen JG, Vles JS: Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. J Child Neurol 2008; 23: 477-481.
15. Wu JY, Kuban KC, Allred E, Shapiro F, Darras BT: Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol 2005; 20: 790-795.
16. Kohane IS, McMurry A, Weber G et al: The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One 2012; 7: e33224.
17. Nakamura AMY, Kumagai T, Suzuki Y, Miura K: Various central nervous system involvements in dystrophinopathy: clinical and genetic considerations. No To Hattatsu 2008; 40: 10-14.
18. Pardo LM, MacKay I, Oostra B, van Duijn CM, Aulchenko YS: The effect of genetic drift in a young genetically isolated population. Ann Hum Genet 2005; 69: 288-295.
19. Hofman A, Darwish Murad S, van Duijn CM et al: The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013; 28: 889-926.
20. Sleegers K, Roks G, Theuns J et al: Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain 2004; 127: 1641-1649.
21. Liu F, Pardo LM, Schuur M et al: The apolipoprotein E gene and its age-specific effects on cognitive function. Neurobiol Aging 2010; 31: 1831-1833.
22. Reitan RM: The relation of the trail making test to organic brain damage. J Consult Psychol 1955; 19: 393-394.
23. Lezak MD, Howieson DB, Loring DW: Neuropsychological Assessment, 4th ed. New York: Oxford University Press, 2004.
24. Welsh KA, Butters N, Mohs RC et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994; 44: 609-614.
25. Golden CJ: Identification of brain disorders by the Stroop Color and Word Test. J Clin Psychol 1976; 32: 654-658.
26. Brouwer RW, van den Hout MC, Grosveld FG, van Ijcken WF: NARWHAL, a primary analysis pipeline for NGS data. Bioinformatics 2012; 28: 284-285.
27. Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
28. Li H, Handsaker B, Wysoker A et al: The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078-2079.
29. McKenna A, Hanna M, Banks E et al: The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297-1303.
30. Aulchenko YS, Ripke S, Isaacs A, van Duijn CM: GenABEL: An R library for genomewide association analysis. Bioinformatics 2007; 23: 1294-1296.
31. Li J, Ji L: Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 2005; 95: 221-227.
32. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X: Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 2011; 89: 82-93.
33. Consortium TG: The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013; 45: 580-585.
34. Voyer D, Voyer S, Bryden MP: Magnitude of sex differences in spatial abilities: A meta-analysis and consideration of critical variables. Psychol Bull 1995; 117: 250-270.
35. Lord C, Rutter M, Goode S et al: Autism diagnostic observation schedule: A standardized observation of communicative and social behavior. J Autism Dev Disord 1989; 19: 185-212.
36. Caron MJ, Mottron L, Berthiaume C, Dawson M: Cognitive mechanisms, specificity and neural underpinnings of visuospatial peaks in autism. Brain 2006; 129: 1789-1802.
37. Shah AFU: Why do autistic individuals show superior performance on the block design task? J Child Psychol Psychiatry 1993; 34: 1351-1364.
38. Pagnamenta AT, Holt R, Yusuf M et al: A family with autism and rare copy number variants disrupting the Duchenne/Becker muscular dystrophy gene DMD and TRPM3. J Neurodev Disord 2011; 3: 124-131.
39. Chung RH, Ma D, Wang K et al: An X chromosome-wide association study in autism families identifies TBL1X as a novel autism spectrum disorder candidate gene in males. Mol Autism 2011; 2: 18.
40. Pellicano E, Maybery M, Durkin K, Maley A: Multiple cognitive capabilities/deficits in children with an autism spectrum disorder: 'weak' central coherence and its relationship to theory of mind and executive control. Dev Psychopathol 2006; 18: 77-98.
41. Ropar D, Mitchell P: Susceptibility to illusions and performance on visuospatial tasks in individuals with autism. J Child Psychol Psychiatry 2001; 42: 539-549.
42. Rumsey JM, Hamburger SD: Neuropsychological findings in high-functioning men with infantile autism, residual state. J Clin Exp Neuropsychol 1988; 10: 201-221.
43. Happe F, Frith U: The weak coherence account: detail-focused cognitive style in autism spectrum disorders. J Autism Dev Disord 2006; 36: 5-25.
44. Muntoni F, Torelli S, Ferlini A: Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003; 2: 731-740.
45. Lidov HG, Byers TJ, Watkins SC, Kunkel LM: Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 1990; 348: 725-728.
46. Sekiguchi M, Zushida K, Yoshida M et al: A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 2009; 132: 124-135.
47. Kueh SL, Head SI, Morley JW: GABA(A) receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice. Clin Exp Pharmacol Physiol 2008; 35: 207-210.
48. Vaillend C, Billard JM: Facilitated CA1 hippocampal synaptic plasticity in dystrophindeficient mice: role for GABAA receptors? Hippocampus 2002; 12: 713-717.
49. Fritschy JM, Schweizer C, Brunig I, Luscher B: Pre-and post-synaptic mechanisms regulating the clustering of type A gamma-aminobutyric acid receptors (GABAA receptors). Biochem Soc Trans 2003; 31: 889-892.
50. Craig AM, Kang Y: Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol 2007; 17: 43-52.
51. Mohler H: Role of GABAA receptors in cognition. Biochem Soc Trans 2009; 37: 1328-1333.
52. Millan MJ, Agid Y, Brune M et al: Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 2012; 11: 141-168.
53. Holder E, Maeda M, Bies RD: Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum Genet 1996; 97: 232-239.
54. Gorecki DC, Monaco AP, Derry JM, Walker AP, Barnard EA, Barnard PJ: Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet 1992; 1: 505-510.
55. Daoud F, Angeard N, Demerre B et al: Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum Mol Genet 2009; 18: 3779-3794.
56. Taylor PJ, Betts GA, Maroulis S et al: Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One 2010; 5: e8803.
57. Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ, Den Dunnen JT: Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006; 34: 135-144.
58. Miyake A, Friedman NP, Rettinger DA, Shah P, Hegarty M: How are visuospatial working memory, executive functioning, and spatial abilities related? A latent-variable analysis. J Exp Psychol 2005; 130: 532-545.
59. Salthouse T: Relations between cognitive abilities and measures of executive functioning. Neuropsychology 2005; 19: 532-545.
60. Ladouceur M, Dastani Z, Aulchenko YS, Greenwood CM, Richards JB: The empirical power of rare variant association methods: results from sanger sequencing in 1998 individuals. PLoS Genet 2012; 8: e1002496.
61. Li B, Leal SM: Methods for detecting associations with rare variants for common diseases: Application to analysis of sequence data. Am J Hum Genet 2008; 83: 311-321.
62. Madsen BE, Browning SR: A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 2009; 5: e1000384.